A Pilot SMART Design for Pathological Gamblers - Full Text View

Sponsor:	University of Connecticut Health Center
Collaborator:	National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):	University of Connecticut Health Center
ClinicalTrials.gov Identifier:	NCT00685724

Purpose

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.

Condition	Intervention	Phase
Pathological Gambling	Behavioral: Motivational Enhancement Therapy (MET) Behavioral: Cognitive-Behavioral Therapy (CBT)	Phase II

Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	A Pilot SMART Design for Pathological Gamblers

Resource links provided by NLM:

MedlinePlus related topics: Compulsive Gambling

U.S. FDA Resources

Further study details as provided by University of Connecticut Health Center:

Primary Outcome Measures:

self and collateral indices of gambling and gambling related problems [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]

Enrollment:	66
Study Start Date:	January 2008
Study Completion Date:	March 2011
Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: 1 Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Experimental: 2 Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Experimental: 3 Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change. Behavioral: Cognitive-Behavioral Therapy (CBT) In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

age > 18 years old, DSM-IV criteria for pathological gambling
>2 gambling episodes in past 60 days
spent >$100 wagering in the past 60 days
willingness to accept random assignment after the brief intervention.

Exclusion Criteria:

Reading level below 5th grade
uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00685724

Locations

United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030

Sponsors and Collaborators

University of Connecticut Health Center

National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator:

Nancy M Petry, Ph.D.

University of Connecticut Health Center

More Information

No publications provided

Responsible Party:	University of Connecticut Health Center
ClinicalTrials.gov Identifier:	NCT00685724 History of Changes
Other Study ID Numbers:	07-259, P50DA009241
Study First Received:	May 23, 2008
Last Updated:	November 17, 2011
Health Authority:	United States: Federal Government; United States: Institutional Review Board

Keywords provided by University of Connecticut Health Center:

pathological gambling
cognitive-behavioral therapy
motivational enhancement therapy

Additional relevant MeSH terms:

Gambling
Impulse Control Disorders
Mental Disorders

ClinicalTrials.gov processed this record on February 12, 2012